• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

MAGA Trade War, mobile CPU ARMS fucked Dotard and Transformed into Chinese Firm

Ang4MohTrump

Alfrescian
Loyal
Joined
Nov 29, 2016
Messages
5,674
Points
63
http://tech.163.com/18/0502/11/DGQ1DFUO00097U7T.html

网易首页 > 网易科技 > IT业界 > 正文

ARM成立合资公司交出中国业务控股权 计划在华上市
2018-05-02 11:06:14 来源: 网易科技报道 举报
0
  • 易信
  • 微信
  • QQ空间
  • 微博
  • 更多
(原标题:Softbank's ARM cedes control of Chinese operations to local joint venture: Nikkei)

35291df8f438410c978a6697e206909b20180502110507.jpeg


网易科技讯 5月2日消息,据英国媒体报道,消息人士透露,软银旗下的ARM控股将把中国业务的控股权出让给其与中国合作伙伴组建的新合资公司。新合资公司在4月开始运营,并计划在国内某一证券交易所上市。


新合资公司名称为ARM mini China,注册地为深圳,其51%的股权为包括国有实体在内的中国投资者所有,其余49%为这家英国芯片公司持有。消息人士称,新合资公司的IPO可能获得监管机构的绿色通道。对此,软银和ARM控股未立即发表评论。

日本电信和投资巨头软银是在2016年以320亿美元收购了英国芯片设计公司ARM。如果ARM mini China成功上市,可帮助软银减少债务,目前该公司债务高达1470亿美元。ARM mini China负责的是ARM公司在中国的技术许可和版税交易。

由于美国政府阻止很多中国公司收购美国芯片公司,这次交易被视为中国获得西方芯片技术的秘密途径。(木秀林)


ARM sets up joint venture company to hand over control of Chinese business plan to be listed in China

2018-05-02 11:06:14 Source: NetEase Science and Technology Report

0

Credulity
WeChat
QQ space
Weibo
More

(Original headline: Softbank's ARM cedes control of Chinese operations to local joint venture: Nikkei)


ARM sets up joint venture company to hand over control of Chinese business plan to be listed in China


Netease Technology News May 2 news, according to British media reports, sources revealed that Softbank’s ARM Holdings will transfer control of the Chinese business to its new joint venture with a Chinese partner. The new joint venture began operations in April and plans to list on a domestic stock exchange.



The name of the new joint venture company is ARM mini China, which is registered in Shenzhen. Its 51% stake is owned by Chinese investors including state-owned entities, and the remaining 49% is held by this British chip company. Sources said that the IPO of the new joint venture company may obtain a green channel from the regulator. In response, Softbank and ARM Holdings did not immediately comment.


Japan Telecom and investment giant Softbank bought the UK chip design company ARM for 32 billion U.S. dollars in 2016. If ARM mini China is successfully listed, it can help Softbank reduce its debt. At present, the company’s debt is as high as US$147 billion. ARM mini China is responsible for ARM's technology licensing and royalty transactions in China.


As the U.S. government prevented many Chinese companies from acquiring U.S. chip companies, the deal was seen as a secret way for China to obtain Western chip technology. (Wood Xiulin)
 
ARM badly needs Chinese Capitals & Chinese Market, and transforming itself into a Chinese market listed firm. Dotard want to use CPU to play Trade War with Chinese? The CPU firm sold itself to the Chinese instead!


https://mrc.ukri.org/funding/browse/uk-china/uk-china-amr-announcement/

Pre-call announcement: UK-China AMR Centre Partnerships Initiative
Please note: This is a pre-call announcement. The UK-China AMR Centre Partnerships Initiative call for proposals is now due to launch on 30 March 2018. More details to follow on the MRC website.
Research Councils UK (RCUK), the strategic partnership of the UK's seven Research Councils and the National Natural Science Foundation of China (NSFC) are pleased to announce they will shortly be launching the UK-China Antimicrobial Resistance (AMR) Centre Partnerships Initiative under the umbrella of the Newton Fund.

This initiative will provide funding for collaborative centre partnerships with the aim of:

  • Supporting large-scale, interdisciplinary collaborative research in AMR and specifically antibacterial resistance
  • Supporting the mobility and exchange of UK and Chinese researchers to enhance links between researchers in both countries.
  • Enhancing existing partnerships and developing new partnerships between the UK and China in the area of AMR.
  • Strengthening the strategic relationship between the UK and China.
In total, RCUK will make up to £8m available to support the UK nodes of 3-5 centre partnerships over a three year period. The UK contribution will be matched by NSFC who will support the Chinese component of the centre partnerships.

The call for proposals will be launched early in 2018, with a deadline for applications in the autumn, and projects commencing in early 2019.

The Newton Fund

The Newton Fund builds scientific and innovation partnerships with 16 partner countries to support their economic development and social welfare, and to develop their research and innovation capacity for long-term sustainable growth. It has a total UK Government investment of £735 million up until 2021, with matched resources from the partner countries. The Newton Fund is managed by the UK Department for Business, Energy and Industrial Strategy (BEIS), and delivered through 15 UK Delivery Partners, which include the Research Councils, the UK National Academies, the British Council, Innovate UK and the Met Office.

For further information visit the Newton Fund homepage and follow via Twitter: @NewtonFund


https://mrc.ukri.org/funding/browse/china-uk-amr/china-uk-amr-partnership-hubs-2018/

China-UK AMR Partnership Hubs 2018
  • Time remaining: 1m 1w 4d 21h 6m
  • Status: Open
  • Open date: 28 Mar 2018
  • Closing date: 14 Jun 2018 16:00 GMT+1
  • Type: Grants, MRC strategic
  • Categories: Infections and immunity, Global health
AMR%20logo.png
NF_NSFC_NNSFC%20logo.png




Please note NSFC will be launching the Call on their website the week commencing 9 April 2018
Contents
The UK Cross Research Council AMR Initiative and the National Natural Science Foundation of China (NSFC) are pleased to invite proposals to the China-UK AMR Partnership Hubs under the umbrella of the Newton Fund.

This initiative will provide funding for high quality collaborative research partnerships focused on addressing the growing global burden of antimicrobial resistance, specifically antibacterial resistance in China.

In total, up to £8m will be made available for this initiative on the UK side with up to 9 million RMB per Partnership Hub from NSFC.

The MRC are leading the UK side of this collaboration on behalf of all the UK Research Councils (Arts and Humanities Research Council (AHRC), Biotechnology and Biological Sciences Research Council (BBSRC), Economic and Social Research Council (ESRC), Engineering and Physical Sciences Research Council (EPSRC), Medical Research Council (MRC), Natural Environment Research Council (NERC) and Science and Technology Facilities Council (STFC) utilising Newton funding.

Background
Antimicrobial resistance (AMR), especially resistance to antibiotics, is a growing problem that does not respect national borders. We are facing a rise in the number of bacteria becoming resistant to existing antibiotics without an increase in new antibiotics or, alternative treatments. The upsurge in resistance is driven by a complex interplay of biomedical, animal, social, cultural and environmental factors. It is clear that an international and interdisciplinary approach is needed to tackle these challenges and make a step change in addressing AMR.

In December 2015, the Medical Research Council (MRC), the Economic and Social Research Council (ESRC), the Biotechnology and Biological Sciences Research Council (BBSRC), as part of the UK Cross Research Council AMR Initiative, and the NSFC launched the China-UK AMR Partnership Initiative. In 2016, this initiative supported six new research partnerships looking at ways of tackling the rise of antibacterial resistance.

These Chinese-UK partnerships brought together leading researchers from both countries, and from multiple research disciplines, to better understand the emergence and spread of resistant bacteria, develop new interventions, and improve health and agricultural systems.

Building on the success of this initiative, in November 2017, the call sponsors held the China-UK AMR Partnership Hubs workshop in Shanghai, China, to provide partnering opportunities and scope this present initiative. The workshop brought together Chinese and UK-based researchers to explore field needs, national strengths and areas of potential complementarity. A summary of workshop proceedings, including a list of attendees, can be found in the China-UK AMR Partnership Hubs Workshop Report.

The current initiative is being run alongside a second, parallel call on China-UK AMR Innovationopens in new window, led in the UK by Innovate UK and the Department of Health, in collaboration with the Chinese Ministry of Science and Technology.

Back to contents.

Aim
This initiative will provide funding for collaborative Partnership Hubs focussed on addressing the challenge of antibacterial resistance (AMR) with the aim of:

  • Enhancing existing partnerships and developing new partnerships between the UK and China in the area of AMR and in particular antibacterial resistance (ABR).
  • Supporting large-scale, interdisciplinary collaborative research.
  • Supporting the mobility and exchange of UK and Chinese researchers to enhance links between researchers in both countries.
  • Strengthening the strategic relationship between the UK and China.
Back to contents.

Objectives
The objective is to deliver significant research funding for internationally competitive and innovative collaborative partnerships between researchers from China and the UK to enable the pursuit of shared research interests.

Back to contents.

Remit
AMR, especially resistance to antibiotics, is a growing global problem. We are facing a rise in the number of bacteria becoming resistant to existing antibiotics without an increase in new antibiotics or new treatments. It is clear that an interdisciplinary approach is needed to tackle these challenges and make a step change in addressing antimicrobial resistance. This call has been launched under the Newton Fund and as such all Partnership Hubs should be collaborative in nature and be focussed on addressing the challenge of antibacterial resistance. Successful applications must demonstrate how they address the needs of the world’s most vulnerable people.

Through this initiative, the funders are seeking to support interdisciplinary Partnership Hubs. As the challenge of ABR arises from a complex interplay between social, economic, cultural, ecological, historical, environmental, technical and biological factors, the funders are encouraging proposals that span these domains. Bids should seek to engage an appropriate range of disciplines and consider the specific social, economic and cultural context of China.

Partnership Hubs that incorporate a systems approach to identifying the primary drivers of resistance in the Chinese context are particularly encouraged. Proposals can include studies of animal and environmental reservoirs of ABR, where these have the potential to spill-over into human populations.

Back to contents.

Scope
In order to address the breadth of the ABR challenge, build on the existing China-UK collaborations, and complement the parallel China-UK AMR Innovation callopens in new window, the following topics are in scope for this call:

  1. Drivers of ABR – eg, understanding the range of drivers and selective pressures of resistance in the Chinese context, to identify where upstream mitigating action to modify the drivers can prevent or reduce the burden or prevalence of ABR.
  2. Pathways for human and livestock exposure – eg, understanding and predictive modelling of acquisition, evolution, persistence and transmission of ABR between environment, animals and humans, and within and between communities and hospitals, to identify effective strategies for diagnosis and infection/disease prevention.
  3. Impacts of ABR – eg, quantifying the burden (environmental, animal and human), social, and economic costs of ABR, to identify the risks, costs and benefits of local interventions.
  4. Responses – eg, drug discovery and alternative treatments/interventions, where a broad interdisciplinary approach is taken.
The scope of this call does not include:

  • Tuberculosis
  • Viral, fungal or parasitic resistance - the current focus of this call is on resistant bacteria of humans and animals but we acknowledge antimicrobial issues in other classes of pathogens are important
  • Resistance in pathogens of relevance to crop health
  • Proposals focused solely on developing or evaluating new targets, therapeutics, diagnostics or interventions to control or treat infections.
Back to contents.

Partnership Hubs
A Partnership Hub is not a physical entity, but rather an agreed collaboration, and a way of working together. The successful Partnership Hubs will be jointly funded by the Newton Fund and NSFC. Each Partnership Hub will develop one node in the UK and one node in China. Each node may comprise a consortium of researchers/research groups, from multiple research disciplines, from one research organisation or more than one organisation. Each Partnership Hub may choose to include separate, but integrated, work packages across the Partnership Hub.

Each Partnership Hub must include a core research programme supported by a range of collaborative activities. Where applicable, project partners should align existing resources and infrastructure to augment the research programme.

The types, and combinations, of activities which can be supported are flexible. The Partnership Hub activities are not prescribed and a programme of activities must be developed and justified by the applicants.

The following activities are a requirement for the call:
  • Joint research projects, together constituting a research programme, between researchers at the partner institutions
  • Resourcing for programme management (associated staff costs must come from the UK budget, all other costs should be sought from the UK or Chinese budget as appropriate)
  • Joint impact and knowledge exchange
Examples of additional activities which could be supported include:
  • Research staff exchanges, including short and longer term visits, exchange of PhD students, post-doctoral researchers and visiting fellows
  • Enabling the sharing of key resources (for example datasets, training guides, protocols for data collection and management) across the partner institutions
  • Supporting wider activities to strengthen links, for example holding symposia, workshops, seminars, meetings etc.
  • Outreach activities, which may include engaging stakeholders, the public, decision makers, policy makers, industry etc.
  • Open access of data and outputs
Back to contents.

Eligibility
This call will fund Partnership Hubs between UK- and China-based researchers working in the area of ABR. It is important to note that:

  • This is an open call; applicants do not need to have attended the China-UK AMR workshop or previously held a China-UK AMR partnership grant in order to apply.
  • The funding agencies will not play a further brokering role in this call.
For support under this call, applicants must be eligible to apply for funding from their respective country’s funding agency:

  • For the UK, applicants must be from an RO eligible for funding from any of the Research Councils, as described on the MRC website. At the time awards are made, the Research Councils will fall under UK Research and Innovation (UKRI).
  • This call is a ‘managed mode’ call being run by the MRC on behalf of the seven UK Research Councils: the Arts and Humanities Research Council (AHRC), the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (EPSRC), the Economic and Social Research Council (ESRC), Medical Research Council (MRC), the Natural Environment Research Council (NERC) and the Science and Technology Facilities Council (STFC), as part of the UK Cross Research Council AMR Initiative.
  • Chinese applicants must be eligible for funding from NSFC and should use the appropriate project code when submitting applications.
All proposals for this call must meet Newton Fund requirements. In particular, proposals must be compliant with Official Development Assistance (ODA) funding rules. For further information see the factsheet "What is ODA?"

Principal Investigators may only submit one application to this scheme as Principal Investigator, but may be involved in more applications if listed as a Co-Investigator.

Applicants with queries regarding eligibility should contact: [email protected]

Back to contents.

Funding available
In total, up to £8m will be made available on the UK side. The UK contribution will be made available to the UK collaborators to fund the UK component of the Partnership Hub. UK based applicants may request £1m - £2m at 80% FEC to cover the UK component of the research projects.

The UK funding agencies will provide funding under standard arrangements and at 80% fEC.

The NSFC’s contribution will be made available to fund the Chinese collaborators. NSFC will make 9 million RMB available to fund the Chinese component of each research project.

The size of the grants will vary according to the needs of each Partnership Hub. Applicants do not need to request equal amounts from both sides. The difference in values should reflect the difference in costs covered and local prices. The agencies also expect the costs on each side to accurately reflect the research effort to be carried out. It is expected, however, that the research effort and intellectual input on both sides should be comparable.

The UK element of funding will not cover capital items.

For further information, please read the scheme specific Guidance for Applicants to the China-UK AMR Partnership Hubs.

Back to contents.

Duration
Projects must start on or before 1 January 2019 in the UK and on the 1 January 2019 in China. Projects must be three years in length in the UK and four years in China and so must have completed by the end of December 2021 (UK) / December 2022 (China).

Back to contents.

Expression of interest
Applicants who wish to apply should submit an expression of interest by 30 April 2018. The expression of interest form must be e-mailed to the following address: [email protected]

The PI at the expression of interest stage must remain the same for the full proposal. Co-Is may change as the proposal develops.

Back to contents.

How to apply
Please note the expression of interest stage detailed above.

UK and Chinese applicants must apply separately to their respective funding agencies by 14 June 2018 for the funding component requested within each country, but this must be based around a common research plan and vision. Both partners must therefore submit an identical joint Case for Support written in English. Failure to submit a valid application to both sponsors will invalidate both submissions.

The MRC is leading this initiative on the UK side on behalf of all the UK funders and as such all UK applicants must submit to the MRC via JeS. JeS submissions must be received by 4pm BST on the day of the deadline.

Applications from the UK Principal Investigator should be submitted to the UK Research Councils’ Joint electronic Submission (Je-S) Systemopens in new window. UK applicants must complete all sections required for a standard Research Council Grant proposal. Please include a two page CV plus a one page list of publications for each of the named investigators (based in China and the UK).

Please also fill in and submit the China-UK Joint Funding Summary form. UK applicants should upload this under the attachment type ‘Letter of Support’.

Justification of Resources, Pathways to Impact and Data Management Plan documents must also be attached to the Je-S application.

For further information, please read the scheme specific Guidance for Applicants to the China-UK AMR Partnership Hubs.

Further guidance can be found in the MRC Guidance for Applicants.

Chinese Principal Investigators must submit an identical case for support written in English to the National Natural Science Foundation of China websiteopens in new window as part of the online submission to NSFC.

Chinese Principal Investigators should use the correct NSFC project code when submitting their applications.

Please remember, all ethical sections must be completed for any relevant activities, whether they take place in China or the UK.

Back to contents.

Key dates
Closing Date for investigators to indicate their intention to submit a proposal 30 April 2018
Deadline for investigators to submit proposal 14 June 2018
External Peer Review 2 July - 14 September 2018
PI response to peer reviews 17 September - 24 September
Panel Meeting w/c 15 October 2018


Grant start dates
Due to funding restrictions of the Newton Fund, grants must start by 1 January 2019. The funding agencies will not afford any leeway on this. Projects funded through this initiative must be three years in length on the UK side and four years in China and must have completed by the end of December 2021 (UK) / December 2022 (China).

Please refer to the MRC Guidance for Applicants for information on what the starting procedure entails; please inform the relevant support staff in your organisation of this requirement to ensure the project starts on time.

Back to contents.

The Newton Fund
The Newton Fund builds scientific and innovation partnerships with 18 partner countries to support their economic development and social welfare, and to develop their research and innovation capacity for long-term sustainable growth. It has a total UK Government investment of £735 million up until 2021, with matched resources from the partner countries. The Newton Fund is managed by the UK Department for Business, Energy and Industrial Strategy (BEIS), and delivered through 15 UK Delivery Partners, which include the Research Councils, the UK National Academies, the British Council, Innovate UK and the Met Office.

For further information visit the Newton Fund homepageopens in new window and follow via Twitter: @NewtonFundopens in new window

Back to contents.
 
Back
Top